0001749272-20-000003.txt : 20200612 0001749272-20-000003.hdr.sgml : 20200612 20200612153221 ACCESSION NUMBER: 0001749272-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200612 DATE AS OF CHANGE: 20200612 EFFECTIVENESS DATE: 20200612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glympse Bio, Inc. CENTRAL INDEX KEY: 0001749272 IRS NUMBER: 474956987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-368862 FILM NUMBER: 20960075 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGEPARK DR. STREET 2: SUITE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-863-3636 MAIL ADDRESS: STREET 1: 35 CAMBRIDGEPARK DR. STREET 2: SUITE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02140 D 1 primary_doc.xml X0708 D LIVE 0001749272 Glympse Bio, Inc. 35 CAMBRIDGEPARK DR. SUITE 100 CAMBRIDGE MA MASSACHUSETTS 02140 617-863-3636 DELAWARE None None Corporation true 2015 Caroline Loew c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Theresia Gouw c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director Amy Schulman c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director Stanley Lapidus c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director Robert Langer c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director Francis Cuss c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director George Zachary c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director Steve Kafka c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Director Tracey Dawson c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Executive Officer Wendy Winckler Adamovich c/o Glympse Bio, Inc. 35 Cambridgepark Dr., Suite 100 Cambridge MA MASSACHUSETTS 02140 Executive Officer Biotechnology Decline to Disclose 06b false 2020-05-29 false true false 0 45000000 26106974 18893026 A certain amount of the Total Remaining to be Sold will be issued and sold upon the achievement by the Company of certain contingencies at a milestone closing. false 18 0 0 0 false Glympse Bio, Inc. /s/ Caroline J. Loew Caroline J. Loew Chief Executive Officer 2020-06-12